Skip to main content
PODD logo

Insulet Corporation

PODDNASDAQHealthcareMedical Devices

$141.10Today:- (-)1Y −56.44%

As of Oct 16, 2026 close

Market cap
$9.63B
P/E (TTM)
25.66
Forward P/E
16.34
Dividend yield
-
52-week range
$126.40$354.88
Volume (live)
-
Avg. volume (3M)
1.61M

Insulet (PODD) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Insulet had a P/E ratio of 80.92 (up from 43.78), return on equity of 18.1% (down from 43.0%), debt-to-equity of 0.66 (down from 1.18) and a current ratio of 2.81 (down from 3.58). A current ratio of 2.81 means current assets exceed current liabilities.

Insulet Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio80.9243.7873.444444.571092.272478.40
Forward P/E49.2670.6793.67227.87227.00-
P/S Ratio7.388.848.9315.6616.7018.64
P/B Ratio13.2015.1120.6842.9232.9927.92
Price/Tangible Book14.8517.2526.0258.5538.2431.50
Price/FCF52.9459.98216.14---
Price/OCF35.1242.57103.99171.81-200.63
PEG Ratio1.872.442.624.802.35-
Enterprise Value Ratios
EV/Revenue7.509.109.3816.1917.0918.67
EV/EBITDA36.0048.3754.35174.91102.39157.93
EV/EBIT42.8761.0372.33366.83149.04327.82
EV/FCF53.7861.75227.10---
Profitability & Returns
Return on Equity (ROE)18.12%43.03%34.13%0.89%2.90%2.00%
Return on Assets (ROA)9.43%6.80%5.69%1.67%4.02%2.14%
Return on Invested Capital (ROIC)19.77%19.52%15.61%2.37%11.58%5.40%
Return on Capital Employed (ROCE)18.90%12.10%10.30%3.10%6.90%3.10%
Leverage & Solvency Ratios
Debt/Equity0.661.181.983.012.311.78
Debt/EBITDA1.743.614.8011.066.799.58
Debt/FCF2.654.7020.67---
Liquidity Ratios
Current Ratio2.813.583.513.605.816.01
Quick Ratio1.812.512.362.414.165.02
Efficiency Ratios
Asset Turnover0.860.730.700.610.560.60
Inventory Turnover1.741.501.431.541.522.52
Yield & Distribution Ratios
Earnings Yield1.24%2.28%1.36%0.02%0.09%0.04%
FCF Yield1.89%1.67%0.46%-0.02%-0.98%-0.27%
Buyback Yield2.71%-0.35%-5.32%-1.94%-3.99%-5.85%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Insulet Financial Ratios

What is Insulet's P/E ratio?

Insulet's P/E ratio was 80.92 for fiscal 2025 (period ended Dec 31, 2025). It was 43.78 a year earlier.

What is Insulet's return on equity?

Insulet's return on equity (ROE) was 18.1% for fiscal 2025 (period ended Dec 31, 2025). It was 43.0% a year earlier.

What is Insulet's debt-to-equity ratio?

Insulet's debt-to-equity ratio was 0.66 for fiscal 2025 (period ended Dec 31, 2025). It was 1.18 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition